29 results
424B3
NVIVQ
InVivo Therapeutics Holdings Corp
21 Nov 22
Prospectus supplement
4:48pm
the INSPIRE 2.0 Study to support our existing Humanitarian Device Exemption application;
the impact of the COVID-19 pandemic on our business;
our ability
424B5
7rs72vi3edzx0gh9
11 Oct 22
Prospectus supplement for primary offering
11:07am
DEFA14A
mivbcr7jz9ozdf
6 Jul 21
Additional proxy soliciting materials
8:10am
8-K
EX-10.1
7wq 2lih7flova9
1 Jun 21
Entry into a Material Definitive Agreement
4:34pm
424B4
fcz9 1o3d9
26 Oct 20
Prospectus supplement with pricing info
12:00am